[Translation] Bioequivalence study of repaglinide metformin tablets in healthy volunteers using an open-label, single-dose, double-cycle, randomized, self-crossover trial design
采用开放、单剂量、双周期、随机、自身交叉试验设计,评价健康志愿者单剂量餐后口服受试制剂瑞格列奈二甲双胍片 2mg/500mg(陕西白鹿制药股份有限公司生产)与参比制剂瑞格列奈二甲双胍片(商品名:PrandiMet)2mg/500mg(Recipharm Stockholm AB 生产)的生物利用度及生物等效性。
[Translation] An open-label, single-dose, double-cycle, randomized, self-crossover trial design was used to evaluate healthy volunteers' single-dose postprandial oral test preparation repaglinide metformin tablets 2mg/500mg (manufactured by Shaanxi Bailu Pharmaceutical Co., Ltd.) and the reference Bioavailability and bioequivalence of formulation repaglinide metformin tablets (trade name: PrandiMet) 2mg/500mg (manufactured by Recipharm Stockholm AB).